The Infectious Disease Diagnostics Market is expected to grow from USD 24.1 billion in 2020 to USD 39.8 billion by 2026 at a CAGR of 7.2% from 2020 to 2026.
Infectious disease diagnosis is referred to as a laboratory test, which is implemented with the help of skilled technicians and physicians to diagnose infectious diseases. It is a diagnostic process in which the effected organism of an infectious disease is featured and identified. The sample of urine, mucus, blood, or other body fluids are analyzed to offer information about the causative organism by the use of several diagnosis procedure and instruments. Growth of the global infectious disease diagnostic market is significantly driven by rise in prevalence of infectious disease such as hepatitis, COVID-19, influenza & human immuno deficiency virus (HIV); surge in demand for point-of-care diagnostic test; rise in funding from private and government organizations for diagnostic service centers; and advancements in technologies in the domain of infectious disease diagnostics. As per the Centers for Disease Control and Prevention (CDC), in 2018, it was reported that about 1.7 million infections and 99,000 related deaths happen every year in American hospitals. Additionally, rise in demand for point-of-care testing is projected to boost the growth of the infection disease diagnostic market. In addition to this, the increase in elderly population compels the infectious disease diagnostic market growth, due to the fact that elderly individuals are more prone to infectious diseases. As per the U.S. Food and Drug Administration (FDA), in 2020, it was reported that almost 300,000 individuals aged 50 and above are diagnosed with pneumococcal pneumonia, every year. In addition, the rise in number of medical laboratories, for infectious disease diagnostic testing is anticipated to the growth of the infection disease diagnostic market. Moreover, the molecular diagnostics has been performed in centralized laboratories since several years; however, the few drawbacks of centralized laboratories are delay in results, high cost of tests, less precision and late disease diagnosis have resulted in continuous shift in decentralizing clinical laboratory testing for infectious disease diagnosis which is also likely to propel the infection disease diagnostic market growth. On the other hand, the unfavorable reimbursement scenario is projected to hinder the market.
Furthermore, the developing nations such as India, Brazil, South Korea, and Mexico are projected to provide lucrative growth opportunities for key players operating in the infectious disease diagnostics market. This can be ascribed to the high disease incidence, huge patient population, developing healthcare infrastructure, rising disposable income, and increasing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has appeared to be an adaptive and business-friendly hub owing to relatively less stringent regulations and data requirements.
The global Infectious Disease Diagnostics Market is segregated on the basis of Product and Service as Instruments, Assays, Reagents, and Kits and Software and Services. Based on Disease Type the global Infectious Disease Diagnostics Market is segmented in Hepatitis, Influenza, Tuberculosis, Human Immunodeficiency Virus and Others.
The global Infectious Disease Diagnostics Market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The Infectious Disease Diagnostics Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Analysis
F. Hoffmann-La Roche Ltd, Abbott Diagnostics, bioMérieux SA, Becton-Dickinson & Company, Siemens Healthineers and others are among the major players in the global Infectious Disease Diagnostics Market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Infectious Disease Diagnostics Market
has been segmented as below: Infectious
Disease Diagnostics Market, By Product and Service Infectious
Disease Diagnostics Market, By Disease Type Infectious
Disease Diagnostics Market, By Region Infectious
Disease Diagnostics Market, By Company The
report covers the below scope: The
years considered for the study are as follows: Report
Scope: The global Infectious Disease Diagnostics Market
report scope includes detailed study covering underlying factors influencing
the industry trends. The report covers analysis on regional and country level
market dynamics. The scope also covers competitive overview providing company
market shares along with company profiles for major revenue contributing
companies. The report scope includes detailed competitive outlook covering
market shares and profiles key participants in the global Infectious Disease
Diagnostics Market share. Major industry players with significant revenue share
include F. Hoffmann-La Roche Ltd, Abbott Diagnostics, bioMérieux
SA, Becton-Dickinson & Company, Siemens Healthineers and others. Why to
Buy this Report: Target
Audience: Free
and Paid Customization based on the requirement
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Infectious Disease Diagnostics Market, By Product and Service
5.1. Key Points
5.2. Instruments
5.3. Assays, Reagents, and Kits
5.4. Software and Services
6. Infectious Disease Diagnostics Market, By Disease Type
6.1. Key Points
6.2. Hepatitis
6.3. Influenza
6.4. Tuberculosis
6.5. Human Immunodeficiency Virus
6.6. Others
7. Competitive Landscape
7.1. Introduction
7.2. Start-up companies- Infectious Disease Diagnostics Market
7.3. Recent Developments
7.3.1. Mergers & Acquisitions
7.3.2. New Product Developments
7.3.3. Portfolio/Production Capacity Expansions
7.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.3.5. Others
8. Company Profile
8.1. F. Hoffmann-La Roche Ltd
8.2. Abbott Diagnostics
8.3. bioMérieux SA
8.4. Becton-Dickinson & Company
8.5. Siemens Healthineers
8.6. Thermo Fischer Scientific, Inc.
8.7. Bio-Rad Laboratories
8.8. Sysmex Corporation
8.9. Beckman Coulter
8.10. Danaher Corporation
8.11. Alere Inc.
8.12. Chembio Diagnostics Inc.
8.13. Cepheid Inc
8.14. DiaSorin
8.15. Meridian Bioscience
8.16. Trinity Biotech
8.17. Sekisui Diagnostics
8.18. Quidel Corporation
8.19. MedMira, Inc.
8.20. Calypte Biomedical Corporation
Infectious Disease Diagnostics Market, By Product and Service
Infectious Disease Diagnostics Market, By Disease Type
Infectious Disease Diagnostics Market, By Company